Aug. 24, 2022 In a survey study of more than 3,000 adults, researchers compared psychedelic experiences with near-death experiences that were not drug related and found notable similarities in people's ...
Aug. 24, 2022 Two doses of psilocybin, a compound found in psychedelic mushrooms, reduces heavy drinking by 83 percent on average among heavy drinkers when combined with psychotherapy, a new study ...
Aug. 22, 2022 Marijuana and hallucinogen use in the past year reported by young adults 19 to 30 years old increased significantly in 2021 compared to five and 10 years ago, reaching historic highs in this age ...
July 27, 2022 Researchers report that common genetic variations in one serotonin receptor could be a reason why people with psychiatric conditions, such as depression, respond differently to psychedelic ...
Apr. 11, 2022 Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new ...
Apr. 11, 2022 A new paper provides a scientific framework to help shape the rollout of a program in Oregon that will legally permit the use of psilocybin for therapeutic ...
Mar. 31, 2022 A new study addresses the question of whether psychedelics might change the attribution of consciousness to a range of living and nonliving ...
Mar. 18, 2022 As Oregon embarks on a voter-approved initiative to permit psychoactive mushrooms in clinical use, a new systematic evidence review reveals a lack of scientific research describing the interactions ...
Mar. 16, 2022 Psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems. But ensuring they do requires ...
Mar. 16, 2022 In the world's largest study on psychedelics and the brain, a team of researchers have shown how drug-induced changes in subjective awareness are anatomically rooted in specific neurotransmitter ...
Feb. 15, 2022 Previous studies have shown that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the ...
Jan. 11, 2022 Researchers have identified the effects of an environmental stressor, sleep deprivation, that could alter the balance controlled by antipsychotic drugs and impact individuals with ...
Oct. 12, 2021 Mushrooms have been making headlines due to their many health advantages. Not only do they lower one's risk of cancer and premature death, but new research also reveals that these super-foods ...
Sep. 14, 2021 Researchers have discovered changes in the brain, triggered by LSD, that may explain the profound altered behavior associated with LSD, helping to understand how the brain generates ...
July 5, 2021 In a new study, researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in ...
May 25, 2021 A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice. Researchers ...
Apr. 28, 2021 Psychedelic drugs have shown promise for treating neuropsychiatric disorders like depression and posttraumatic stress disorder. However, due to their hallucinatory side effects, some researchers are ...
Apr. 13, 2021 Researchers have shown that psilocybin -- the active chemical in 'magic mushrooms' -- still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is ...
Mar. 22, 2021 As psychedelics gain ground as a potential therapy for mental health disorders, there remains a pressing concern that patients in clinical trials may have adverse effects to the drugs. New research ...